<DOC>
	<DOCNO>NCT02141113</DOCNO>
	<brief_summary>This consider investigator-initiated clinical research trial , mean study doctor research particular medication ( case medication currently FDA- approve ) treatment AD/HD individual age 6-17 . The medication guanfacine hydrochloride . The hypothesis medication could use adult Attention Deficit/Hyperactivity Disorder receive satisfactory result current stimulant ADHD medication . The study drug investigational use adult . Investigational mean approve U.S. Food Drug Administration ( FDA ) use adult .</brief_summary>
	<brief_title>Efficacy Safety Eval Guanfacine Hydrochloride Combination With Psychostimulants Adults ( 18-65 ) .</brief_title>
	<detailed_description>The purpose study determine whether guanfacine hydrochloride use adjunct therapy ( subject ' current stimulant medication ) would bring statistically significant improvement AD/HD symptom .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<criteria>Inclusion : Male female ( non pregnant ) age 1865 Current diagnosis ADHD meet DSMIVTR criterion ADHD Currently take adequate dose stimulant treat ADHD ( suboptimal response ) . A suboptimal response determine baseline score 28 great ADHDRS CGI score 4 great . Subjects must normal intelligence English speaking Able swallow pill . Exclusion : Non pregnant lactating female Severe Axis I Axis II disorder Suicidal Tourette 's Heart disease serious chronic acute unstable medical conditions/illnesses would compromise participation likely lead hospitalization duration study . A known history presence cardiovascular , hepatic , renal , respiratory , hematologic abnormality , narrow angle glaucoma , unstable medical psychiatric condition ( judge primary investigator ) A current recent history ( within past 6 month ) suspect substance abuse and/or drug dependence define DSMIVTR criterion Healthy weight ( judged investigator ) No immediate family member investigator research staff No involvement research study last 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>